Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
暂无分享,去创建一个
I. Melero | A. Muntasell | M. López-Botet | B. Paiva | P. Berraondo | A. Zabaleta | M. Sanmamed | D. Alignani | M. Ochoa | Luna Minute | E. Pérez-Ruiz | Ascensión López | Myriam Fernández-Sendin | C. Oñate | G. Pérez | I. Rodriguez